FDMT

4D Molecular Therapeutics Inc (FDMT)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 256.18M
P/E Ratio
0.00
Revenue (TTM)
$ 23K
Volume
0
52W High
$ 17.41
52W Low
$ 2.23
Dividend Yield
0.00%
Beta
2.82

Technicals

50-Day MA
4.4454
200-Day MA
5.0019
52 Week High
17.41
52 Week Low
2.235

About FDMT

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic .

Employees
227
Headquarters
EmeryVille, CA
CEO
Dr. John F. Milligan Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg